Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics

Cell Proliferation

Volumn 29, Issue 10, 1996, Pages 525-538

  Johansson, M C ^a   Baldetorp, B ^a   Bendahl, P O ^a   Fadeel, I A ^a   Oredsson, S M ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL LINE; CELL POPULATION; CELL PROLIFERATION; CHEMOTHERAPY; COMPARATIVE STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; HAMSTER; HUMAN; HUMAN CELL; KINETICS; MATHEMATICAL MODEL; MODEL; NONHUMAN; PREDICTION; TUMOR GROWTH;

ANIMALIA; CRICETINAE;

EID: 0030499758     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1996.tb00968.x     Document Type: Article

References (41)

1. BALDETORP B, DALBERG M, HOLST U, LINDGREN G. (1989) Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 10, 695.
2. BEGG AC. (1993) Critical appraisal of in situ cell kinetic measurements as response predictors in human tumors. Semin. Radiat. Oncol. 3, 144.
3. BEGG AC, HOFLAND I, MOONEN L et al. (1990) The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int. J. Radiat. Oncol. Biol. Phys. 19, 1449.
4. BEGG AC, HOFLAND I, VAN GLABEKKE M, BARTELINK H, HORIOT JC. (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 2, 22.
5. BEGG AC, MCNALLY NJ, SHRIEVE DC, KÄRCHER H. (1985) A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6, 620.
6. BOURHIS J, WILSON G, WIBAULT P et al. (1993) In vivo measurement of the potential doubling time by flowcytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26, 793.
7. CHAUVEL P, COURDI A, GIOANNI J, VALLICIONI J, SANTINI J, DEMARD F. (1989) The labelling index: a prognostic factor in head and neck carcinoma. Radiother. Oncol. 14, 231.
8. CORVÒ R, GIARETTI W, SANGUINETI G et al. (1993) Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int. J. Radiat. Oncol. Biol. Phys. 27, 1165.
9. CORVÒ R, GIARETTI W, SANGUINETI G et al. (1995) In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol. 13, 1843.
10. DOLBEARE F, GRATZNER H, PALLAVICINI MG, GRAY JW. (1983) Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80, 5573.
11. FOWLER JF. (1986) Potential for increasing the differential response between tumors and normal tissues: can proliferation rate by used? Int. J. Radiat. Oncol. Biol. Phys. 12, 641.
12. GRATZNER HG, LEIF RC. (1981) An immunofluorescence method for monitoring DNA synthesis by flow cytometry. Cytometry 1, 385.
13. HAUSTERMANS K, HOFLAND I, POTTIE G, RAMAEKERS M, BEGG AC. (1995) Can measurements of potential doubling time (Tpot) be compared between laboratories? A quality control study. Cytometry 19, 154.
14. HORIOT JC, BEGG AC, LE FUR R et al. (1994) Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma. Recent Results Cancer Res. 134, 111.
15. JOHANSSON MC, BALDETORP B, BENDAHL PO, JOHANSSON R, OREDSSON SM. (1994) An improved mathematical method to estimate DNA synthesis time of bromodeoxyuridine-labelled cells, using FCM-derived data. Cell Prolif. 27, 475.
16. LOCHRIN CA, WILSON GD, MCNALLY NJ, DISCHE S, SAUNDERS MI. (1992) Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 24, 87.
17. MEYER JS, PROVINCE M. (1988) Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors. Breast Cancer Res. Treat. 12, 191.
18. NISHIZAKI T, ORITA T, KAJIWARA K et al. (1990) Correlation of in vitro bromodeoxyuridine labeling index and DNA aneuploidy with survival or recurrence in brain-tumor patients. J. Neurosurg. 73, 396.
19. PETERS LJ, BROCK WA, CHAPMAN JD, WILSON G. (1988) Predictive assays of tumor radiocurability. Am. J. Clin. Oncol. 11, 275.
20. REMVIKOS Y, JOUVE M, BEUZEBOC P, VIEHL P, MAGDELÉNAT H, POUILLART P. (1993) Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. Eur. J. Cancer 29A, 1843.
21. RICCARDI A, GIORDANO M, DANOVA M et al. (1991) Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur. J. Cancer 27, 882.
22. RITTER MA, FOWLER JF, KIM Y, LINDSTROM MJ, KINSELLA TJ. (1992) Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. Int. J. Radiat. Oncol. Biol. Phys. 23, 811.
23. SCHUTTE B, REYNDERS MMJ, VAN ASSCHE CLMVJ, HUPPERETS PSGJ, BOSMAN FT, BLIJHAM GH. (1987) An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry 8, 372.
24. SIGURDSSON H, BALDETORP B, BORG Å et al. (1990) Indicators of prognosis in node-negative breast cancer. N. Engl. J. Med. 322, 1045.
25. 3H-Thymidine-labeling index as a prognostic indicator in node-positive breast cancer. J. Clin. Oncol. 8, 1321.
26. STEEL GG. (1977) Growth Kinetics of Tumours. Oxford: Clarendon Press.
27. TERRY NHA, PETERS LJ. (1995) The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis. J. Clin. Oncol. 13, 1833.
28. TERRY NHA, MEISTRICH ML, ROUBEIN LD, LYNCH PM, DUBROW RA, RICH TA. (1995) Cellular kinetics in rectal cancer. Br. J. Cancer 72, 435.
29. TERRY NHA, WHITE RA, MEISTRICH ML, CALKINS DP. (1991) Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry 12, 234.
30. THORNTHWAITE JT, SUGARBAKER EV, TEMPLE WJ. (1980) Preparation of tissues for DNA flow cytometric analysis. Cytometry 1, 229.
31. TSANG RW, FYLES AW, KIRKBRIDE P et al. (1995) Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int. J. Radiat. Oncol. Biol. Phys. 32, 1319.
32. TUBIANA M, COURDI A. (1989) Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother. Oncol. 15, 1.
33. TUCKER SL, CHAN K-S. (1990) The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and intrinsic radiosensitivity. Radiother. Oncol. 18, 197.
34. WENNERBERG J. (1984) Changes in growth pattern of human squamous-cell carcinomas of the head and neck during serial passages in nude mice. Int. J. Cancer 33, 245.
35. WHITE RA, MEISTRICH ML. (1986) A comment on 'A method to measure the duration of DNA synthesis and the potential doubling time from a single sample'. Cytometry 7, 486.
36. WHITE RA, TERRY NHA, MEISTRICH ML, CALKINS DP. (1990) Improved method for computing potential doubling time from flow cytometric data. Cytometry 11, 314.
37. WILSON GD. (1992) The future of flow cytometry. Br. J. Radiol. Suppl. 24, 158.
38. WILSON GD, DISCHE S, SAUNDERS MI. (1995) Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36, 189.
39. WILSON GD, MCNALLY NJ, DISCHE S et al. (1988) Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer 58, 423.
40. WILSON MS, WEST CML, WILSON GD, ROBERTS SA, JAMES RD, SCHOFIELD PF. (1993) An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers. Br. J. Cancer 67, 754.
41. VISSCHER DW, ZARBO RJ, GREENAWALD KA, CRISSMAN JD. (1990) Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Pathol. Annu. 1, 171.